These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12522763)

  • 21. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
    Peuchant O; Ménard A; Renaudin H; Morozumi M; Ubukata K; Bébéar CM; Pereyre S
    J Antimicrob Chemother; 2009 Jul; 64(1):52-8. PubMed ID: 19429926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
    Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG
    Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.
    Doktor SZ; Shortridge VD; Beyer JM; Flamm RK
    Diagn Microbiol Infect Dis; 2004 May; 49(1):47-52. PubMed ID: 15135500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
    Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
    Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary lung abscess caused by multidrug-nonsusceptible Streptococcus pneumoniae in a child.
    Holston AM; Miller JR
    Pediatr Infect Dis J; 2006 Feb; 25(2):182-3. PubMed ID: 16462303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
    Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
    Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes.
    Jalava J; Vaara M; Huovinen P
    Ann Clin Microbiol Antimicrob; 2004 May; 3():5. PubMed ID: 15128458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
    Dobay O; Rozgonyi F; Amyes SG
    Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
    Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
    Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
    Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneous macrolide resistance and gene conversion in the pneumococcus.
    Wolter N; Smith AM; Farrell DJ; Klugman KP
    Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.